Molly Duckett, PharmD is the 2024-25 Community Pharmacy PGY-1 resident in collaborative Walgreens-Florida A&M University setting
Jacksonville, FL – Molly Duckett, PharmD is the 2024-25 Community Pharmacy PGY-1 resident at Walgreens-FAMU CoPPS, IPH, PGY-1 Community Based Residency Program according to Quovadis Epps, PharmD, MS, BCPS, Associate Professor of Pharmacy in the FAMU CoPPS, IPH, Northeast Florida Pharmacy Practice Center in Jacksonville, FL. Speaking with Dr. Epps, she emphasized: “We are excited to welcome Molly to the CoPPS, IPH FAMUly! Molly has successfully passed both the NAPLEX and MPJE and will be instrumental in the continuous development of our program and the ASHP accreditation process that will occur in 2025.” Accreditation - ASHP.
The PGY-1 Pharmacy Residency is a 12-month postgraduate ASHP-accredited program that
provides a structured, directed, and professional learning experience. The program
builds on previous education and experience and is directed toward developing a generalist
expert knowledge and skills in pharmacotherapy management. Residency Program Resources - ASHP Dr. Duckett will benefit from Walgreens’ multi-faceted pharmacy proficiencies, coupled
with FAMU pharmacy practice exposure to didactic teaching opportunities and more.
Dr. Duckett is originally from Cartersville, Georgia. She received her Bachelor of
Science in Pharmaceutical Sciences and Doctor of Pharmacy from the University of Georgia The University of Georgia College of Pharmacy (uga.edu) in 2020 and 2024, respectively. Molly’s professional interests are academia and outpatient
specialty pharmacy including Human Immunodeficiency Virus (HIV), transplant, and chronic
inflammatory disease states. In her free time, Molly enjoys both attending and watching
Georgia Bulldogs and Atlanta Braves sporting events with her husband, listening to
true crime podcasts, and reading mystery novels.
She joins the previously acknowledged ASHP residency matches from the FAMU CoPPS, IPH https://conta.cc/3KdNHwu and the FAMU CoPPS, IPH provides the venue for her continual growth and development in pharmacy practice. Benefits of collaborative practice agreements include improved health outcomes, optimized medical use, delivery of quality patient care, promoting the recognition of pharmacy services, and attaining the goals of CMS Pharmacist Center | CMS, which inclines toward cost-efficient measures of meeting complex patient needs. Once again, collaboration counts with the FAMU CoPPS, IPH!
